Close Menu

NEW YORK (360Dx) – Genesis Biotechnology Group announced today that it has acquired the assets of 4path, an Illinois-based anatomic and clinical pathology lab.

According to Genesis, the acquisition is expected to expand the reach of its diagnostics branch — which includes Hamilton, New Jersey-based Medical Diagnostic Laboratories — and allow it to establish a rapid response clinical lab in the Midwest.

Specific terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.